» Articles » PMID: 32504025

High-profile Coronavirus Retractions Raise Concerns About Data Oversight

Overview
Journal Nature
Specialty Science
Date 2020 Jun 7
PMID 32504025
Citations 39
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

Schilling W, Mukaka M, Callery J, Llewelyn M, Cruz C, Dhorda M PLoS Med. 2024; 21(9):e1004428.

PMID: 39264960 PMC: 11392261. DOI: 10.1371/journal.pmed.1004428.


Addressing researcher fraud: retrospective, real-time, and preventive strategies-including legal points and data management that prevents fraud.

Kennedy J Front Res Metr Anal. 2024; 9:1397649.

PMID: 38993994 PMC: 11236558. DOI: 10.3389/frma.2024.1397649.


Ten principles for generating accessible and useable COVID-19 environmental science and a fit-for-purpose evidence base.

Kadykalo A, Haddaway N, Rytwinski T, Cooke S Ecol Solut Evid. 2024; 2(1):e12041.

PMID: 38607812 PMC: 7994966. DOI: 10.1002/2688-8319.12041.


Analysis of Retracted Manuscripts in Chemistry: Errors vs Misconduct.

Sevryugina Y, Jimenez R ACS Omega. 2023; 8(35):31568-31574.

PMID: 37692206 PMC: 10483516. DOI: 10.1021/acsomega.3c03689.


Relationship between journal impact factor and the thoroughness and helpfulness of peer reviews.

Severin A, Strinzel M, Egger M, Barros T, Sokolov A, Mouatt J PLoS Biol. 2023; 21(8):e3002238.

PMID: 37643173 PMC: 10464996. DOI: 10.1371/journal.pbio.3002238.


References
1.
Mehra M, Ruschitzka F, Patel A . Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020; 395(10240):1820. PMC: 7274621. DOI: 10.1016/S0140-6736(20)31324-6. View

2.
Kapitola J, Vilimovska D . Influence of theophylline on the circulatory actions of thyroid hormones. Endokrinologie. 1981; 77(3):375-6. View

3.
Boulware D, Pullen M, Bangdiwala A, Pastick K, Lofgren S, Okafor E . A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020; 383(6):517-525. PMC: 7289276. DOI: 10.1056/NEJMoa2016638. View